Targeting ALK in Neuroendocrine Tumors of the Lung

BACKGROUND: Anaplastic lymphoma kinase (ALK) rearrangements are known oncogenic drivers in non-small cell lung cancer (NSCLC). Few case reports described the occurrence of such rearrangements in large cell neuroendocrine carcinomas (LCNECs) of the lung without information on clinical responses to AL...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhoundova, Dilara, Haberecker, Martina, Fritsch, Ralph, Höller, Sylvia, Kiessling, Michael K., Rechsteiner, Markus, Rüschoff, Jan H., Curioni-Fontecedro, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214311/
https://www.ncbi.nlm.nih.gov/pubmed/35756632
http://dx.doi.org/10.3389/fonc.2022.911294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214311/
https://www.ncbi.nlm.nih.gov/pubmed/35756632
http://dx.doi.org/10.3389/fonc.2022.911294

Ejemplares similares